• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

    10/25/23 8:03:08 AM ET
    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Semiconductors
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ASTI alert in real time by email

    Gainers

    • ReShape Lifesciences Inc. (NASDAQ:RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering.
    • Nuvve Holding Corp. (NASDAQ:NVVE) shares gained 30% to $0.1931 in pre-market trading after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share.
    • NextPlat Corp (NASDAQ:NXPL) shares rose 28.6% to $2.26 in pre-market trading after gaining over 3% on Tuesday.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) rose 25.7% to $0.4832 in pre-market trading after gaining around 4% on Tuesday.
    • LumiraDx Limited (NASDAQ:LMDX) gained 24.7% to $0.1933 in pre-market trading after dipping around 44% on Tuesday.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) shares rose 16.5% to $1.41 in pre-market trading. Cognition Therapeutics presented complete EEG findings from SEQUEL study of CT1812 in mild-to-moderate Alzheimer's disease at the Clinical Trials on Alzheimer’s Disease (CTAD) conference.
    • BioVie Inc. (NASDAQ:BIVI) shares climbed 16.4% to $3.90 in pre-market trading after gaining around 3% on Tuesday.
    • Sonendo, Inc. (NYSE:SONX) shares jumped 15.2% to $0.2650 in pre-market trading after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter.
    • Recon Technology, Ltd. (NASDAQ:RCON) rose 12.1% to $0.2988 in pre-market trading.
    • Microsoft Corporation (NASDAQ:MSFT) shares rose 3.6% to $342.51 in pre-market trading as the company posted stronger-than-expected results for its fiscal first quarter on Tuesday. Piper Sandler maintained Microsoft with an Overweight and raised the price target from $400 to $425.

    Losers

    • Appreciate Holdings, Inc. (NASDAQ:SFR) dipped 32.7% to $0.1001 in pre-market trading. Appreciate Holdings received a notice from Nasdaq regarding delisting.
    • Intrusion Inc. (NASDAQ:INTZ) shares fell 28.1% to $0.2479 in pre-market trading after declining over 7% on Tuesday.
    • Tharimmune, Inc. (NASDAQ:THAR) shares fell 25.1% to $0.1888 in pre-market trading after jumping 34% on Tuesday.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) shares fell 23.2% to $0.76 in pre-market trading. InMed Pharmaceuticals announced a $5.2 million private placement and preferred investment option exercise priced at-the-market under Nasdaq rules.
    • Vicor Corporation (NASDAQ:VICR) fell 20.8% to $42.11 in pre-market trading after reporting results for the third quarter.
    • Alphatec Holdings, Inc. (NASDAQ:ATEC) shares fell 14.5% to $10.96 in pre-market trading after the company priced underwritten public offering of 14.3 million common shares at $10.50 per share.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) fell 13.8% to $1.56 in pre-market after declining 12% on Tuesday.
    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) shares fell 12.5% to $1.05 in pre-market trading. Ascent Solar shares jumped 22% on Tuesday after the company announced the initial concept paper submitted for DE-FOA-000305 has been reviewed and received an "Encouraged" decision from the DOE.
    • Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) fell 10.2% to $2.02 in pre-market trading. Lipella Pharmaceuticals announced a $2 million private placement priced at-the-market under Nasdaq rules.
    • Alphabet Inc. (NASDAQ:GOOGL) shares fell 6.8% to $129.42 in pre-market trading. Alphabet reported better-than-expected earnings and sales results for its third quarter, but recorded downbeat performance for its cloud computing unit.

    Now Read This: Boeing, Microsoft And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ASTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTI
    $ATEC
    $BIVI
    $BRSH

    CompanyDatePrice TargetRatingAnalyst
    Microsoft Corporation
    $MSFT
    2/9/2026Buy → Hold
    Melius
    Microsoft Corporation
    $MSFT
    2/5/2026$392.00Buy → Hold
    Stifel
    Microsoft Corporation
    $MSFT
    2/3/2026$600.00Overweight
    Piper Sandler
    Microsoft Corporation
    $MSFT
    1/29/2026$610.00 → $600.00Overweight
    Barclays
    Microsoft Corporation
    $MSFT
    1/29/2026$600.00 → $540.00Outperform
    Robert W. Baird
    Microsoft Corporation
    $MSFT
    1/29/2026$655.00 → $600.00Buy
    Goldman
    Microsoft Corporation
    $MSFT
    1/29/2026$630.00 → $615.00Overweight
    Wells Fargo
    Microsoft Corporation
    $MSFT
    1/29/2026$660.00 → $635.00Buy
    Citigroup
    More analyst ratings

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Scott Anthony bought $2,126 worth of shares (2,175 units at $0.98), increasing direct ownership by 0.34% to 638,793 units (SEC Form 4)

    4 - INTRUSION INC (0000736012) (Issuer)

    1/12/26 7:57:35 AM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    Chief Financial Officer Pinson Kimberly bought $2,444 worth of shares (2,500 units at $0.98), increasing direct ownership by 4% to 61,154 units (SEC Form 4)

    4 - INTRUSION INC (0000736012) (Issuer)

    1/12/26 7:58:01 AM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    Vice Chair and President Smith Bradford L bought $1,450,221 worth of shares (3,842 units at $377.46) and sold $1,684,498 worth of shares (3,842 units at $438.44) (SEC Form 4)

    4 - MICROSOFT CORP (0000789019) (Issuer)

    12/12/25 6:20:17 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

    CARSON CITY, Nev., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of two abstracts from studies on its lead candidate bezisterim (NE3107), in the treatment of Alzheimer's Disease and Long COVID at the 2026 American College of Psychiatrists (ACP) annual meeting, to be held February 18-22, in Bonita Springs, FL. The two abstracts have been accepted for presentation as posters during a session to be held on February 18, 2026. Details of the abstracts are as follows: Abstract Title: Bezisterim-Associated Anti-i

    2/12/26 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

    Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, wh

    2/6/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vicor Corporation to Hold Fourth Quarter Earnings Conference Call and Webcast on February 19, 2026

    ANDOVER, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ:VICR) announced today it will hold its fourth quarter 2025 earnings conference call and webcast on Thursday, February 19, 2026 at 5:00 p.m. (Eastern). Prepared remarks regarding the company's financial and operational results for the three and twelve months ended December 31, 2025 will be followed by a question and answer period with Patrizio Vinciarelli, Chief Executive Officer, Jim Schmidt, Chief Financial Officer, and Phil Davies, Corporate Vice President, Global Sales and Marketing. Results for the fourth quarter will be released over GlobeNewswire at the close of the NASDAQ Market Session on February 19, 2026

    2/5/26 2:15:31 PM ET
    $VICR
    Industrial Machinery/Components
    Technology

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    SEC Filings

    View All

    SEC Form 424B3 filed by Ascent Solar Technologies Inc.

    424B3 - Ascent Solar Technologies, Inc. (0001350102) (Filer)

    2/12/26 4:10:14 PM ET
    $ASTI
    Semiconductors
    Technology

    SEC Form EFFECT filed by Ascent Solar Technologies Inc.

    EFFECT - Ascent Solar Technologies, Inc. (0001350102) (Filer)

    2/12/26 12:15:15 AM ET
    $ASTI
    Semiconductors
    Technology

    InMed Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    2/11/26 8:51:22 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Microsoft downgraded by Melius

    Melius downgraded Microsoft from Buy to Hold

    2/9/26 9:08:06 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    Microsoft downgraded by Stifel with a new price target

    Stifel downgraded Microsoft from Buy to Hold and set a new price target of $392.00

    2/5/26 6:54:30 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    Piper Sandler resumed coverage on Microsoft with a new price target

    Piper Sandler resumed coverage of Microsoft with a rating of Overweight and set a new price target of $600.00

    2/3/26 6:56:06 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 13, 2021 - FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions

    For Immediate Release: May 13, 2021 The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response “The FDA has been working with the CDC, state partners and Canadian officials to investigate the largest Salmonella Newport outbreak in over a decade, which was linked to red onions. The FDA, today, released a 2020 Salmonella Outbreak Linked to Red Onions Report that includes an o

    5/13/21 3:17:14 PM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hennessy John L. gifted 1,765 units of Class C Capital Stock and received a gift of 1,765 units of Class C Capital Stock, decreasing direct ownership by 100% to 1 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/12/26 7:19:00 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    SEC Form 3 filed by new insider Radkowski Angela Dominy

    3 - Tharimmune, Inc. (0001861657) (Issuer)

    2/11/26 5:20:49 PM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Sommers Jill E.

    3 - Tharimmune, Inc. (0001861657) (Issuer)

    2/11/26 5:18:29 PM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Leadership Updates

    Live Leadership Updates

    View All

    Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

    Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, wh

    2/6/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

    New Directors Strengthen Governance as Company Advances Canton Network Infrastructure Former CFTC Commissioner Jill Sommers Brings Decades of Regulatory and Public Policy Experience DRW Chief of Staff William Wiley, CFA, Adds Extensive Leadership Experience Across Capital Markets and Global Operations NEW YORK, Feb. 2, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Jill Sommers and William Wiley, CFA, to the Board, effective February 1, 20

    2/2/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

    Former Clear Street Group CFO Strengthens Leadership Team Alongside Industry Veterans Mark Wendland and Mark Toomey Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced the appointment of seasoned financial executive Jacob Asbury as Chief Financial Officer, effective immediately. In this role, he will oversee all financial strategy and operations, including capital planning, treasury management, financial reporting, and the continued expansion of Tharimmune's CC treasury infrastructure. Mr. Asbury brings nearly two d

    12/12/25 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Vicor Corporation

    SC 13G/A - VICOR CORP (0000751978) (Subject)

    12/4/24 2:38:58 PM ET
    $VICR
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by Lipella Pharmaceuticals Inc.

    SC 13G/A - LIPELLA PHARMACEUTICALS INC. (0001347242) (Subject)

    11/14/24 5:09:22 PM ET
    $LIPO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Lipella Pharmaceuticals Inc.

    SC 13G/A - LIPELLA PHARMACEUTICALS INC. (0001347242) (Subject)

    11/14/24 5:00:15 PM ET
    $LIPO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASTI
    $ATEC
    $BIVI
    $BRSH
    Financials

    Live finance-specific insights

    View All

    Vicor Corporation to Hold Fourth Quarter Earnings Conference Call and Webcast on February 19, 2026

    ANDOVER, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ:VICR) announced today it will hold its fourth quarter 2025 earnings conference call and webcast on Thursday, February 19, 2026 at 5:00 p.m. (Eastern). Prepared remarks regarding the company's financial and operational results for the three and twelve months ended December 31, 2025 will be followed by a question and answer period with Patrizio Vinciarelli, Chief Executive Officer, Jim Schmidt, Chief Financial Officer, and Phil Davies, Corporate Vice President, Global Sales and Marketing. Results for the fourth quarter will be released over GlobeNewswire at the close of the NASDAQ Market Session on February 19, 2026

    2/5/26 2:15:31 PM ET
    $VICR
    Industrial Machinery/Components
    Technology

    Microsoft earnings press release available on Investor Relations website

    REDMOND, Wash., Jan. 28, 2026 /PRNewswire/ -- Microsoft Corp. on Wednesday announced that fiscal year 2026 second-quarter financial results are available on its Investor Relations website. The direct link to the earnings press release is https://www.microsoft.com/en-us/Investor/earnings/FY-2026-Q2/press-release-webcast. As previously announced, the company will host a conference call at 2:30 p.m. Pacific Time. A live webcast of the call can be accessed on Microsoft's Investor Relations website at https://www.microsoft.com/en-us/Investor/. Microsoft (Nasdaq "MSFT" @microsoft) c

    1/28/26 4:05:00 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

    Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended December 31, 2025 Surgical Revenue $189.3M to $190.0M $686.3M to

    1/12/26 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care